Addition of the Akt inhibitor triciribine overcomes antibody resistance in cells from ErbB2/Neu-positive/PTEN-deficient mammary tumors

By              

International Journal of Oncology, Vol. 44, Iss. 4, 2014-01 ,pp. : 1277-1283

Spandidos Publications

Access to resources Recommend Favorite

Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior

By Borowsky Alexander   Namba Ruria   Young Lawrence   Hunter Kent   Hodgson J.   Tepper Clifford   McGoldrick Erik   Muller William   Cardiff Robert   Gregg Jeffrey  

Clinical and Experimental Metastasis, Vol. 22, Iss. 1, 2005-03 ,pp. : 47-59

Springer Publishing Company

Access to resources Recommend Favorite

ErbB4 is downregulated in renal cell carcinoma

By Thomasson Marcus   Hedman Håkan   Junttila Teemu   Elenius Klaus   Ljungberg Börje   Henriksson Roger  

Acta Oncologica, Vol. 43, Iss. 5, 2004-07 ,pp. : 453-459

Informa Healthcare

Access to resources Recommend Favorite

Trisomy chromosome 5 is a recurrent cytogenetic lesion in mammary tumors from parous MMTV-erbB-2 transgenic mice

By Kim Young Mi   Ma Zhikun   Lee Seungjik   Lee Jiyun   Li Shibo   Yang Xiaohe  

Oncology Letters, Vol. 2, Iss. 6, 2011-11 ,pp. : 1077-1081

Spandidos Publications

Access to resources Recommend Favorite

Suppression of Diacylglycerol Levels by Antibodies Reactive with the c-erbB-2 (HER-2/neu) Gene Product p185 c-erbB-2 in Breast and Ovarian Cancer Cell Lines

By Boente M.P.   Berchuck A.   Whitaker R.S.   Kalen A.   Xu F.-J.   Clarke-Pearson D.L.   Bell R.M.   Bast R.C.  

Gynecologic Oncology, Vol. 70, Iss. 1, 1998-07 ,pp. : 49-55

Elsevier

Access to resources Recommend Favorite